Cargando…
Characterization of Lysine Acetyltransferase Activity of Recombinant Human ARD1/NAA10
Arrest defective 1 (ARD1), also known as N(alpha)-acetyltransferase 10 (NAA10) was originally identified as an N-terminal acetyltransferase (NAT) that catalyzes the acetylation of N-termini of newly synthesized peptides. After that, mammalian ARD1/NAA10 expanded its’ role to lysine acetyltransferase...
Autores principales: | Vo, Tam Thuy Lu, Park, Ji-Hyeon, Lee, Eun Ji, Nguyen, Yen Thi Kim, Han, Byung Woo, Nguyen, Hien Thi Thu, Mun, Kyo Cheol, Ha, Eunyoung, Kwon, Taeg Kyu, Kim, Kyu-Won, Jeong, Chul-Ho, Seo, Ji Hae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036845/ https://www.ncbi.nlm.nih.gov/pubmed/32013195 http://dx.doi.org/10.3390/molecules25030588 |
Ejemplares similares
-
Versatility of ARD1/NAA10-mediated protein lysine acetylation
por: Vo, Tam Thuy Lu, et al.
Publicado: (2018) -
N-α-acetyltransferase 10 (NAA10) in development: the role of NAA10
por: Lee, Mi-Ni, et al.
Publicado: (2018) -
ARD1/NAA10 in hepatocellular carcinoma: pathways and clinical implications
por: Lee, Danbi, et al.
Publicado: (2018) -
NAA10 as a New Prognostic Marker for Cancer Progression
por: Kim, Sun Myung, et al.
Publicado: (2020) -
ARD1-mediated aurora kinase A acetylation promotes cell proliferation and migration
por: Vo, Tam Thuy Lu, et al.
Publicado: (2017)